ArticleHuman gene therapy2023

Safety of Intravenous Administration of an AAV8 Vector Coding for an Oxidation-Resistant Human α1-Antitrypsin for the Treatment of α1-Antitrypsin Deficiency.

Jonathan B Rosenberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.